<?xml version="1.0" encoding="UTF-8"?>
<p>The involvement of the ERα in neurodegenerative diseases is of particular importance in light of the sex differences that characterize these diseases and because the basis of these differences are largely unknown (
 <xref rid="CIT0014" ref-type="bibr">14</xref>). However, an initial enthusiasm for the use of ERα ligands in neurodegeneration has since declined, due to their failure to improve clinical outcomes in several diseases (
 <xref rid="CIT0015" ref-type="bibr">15-18</xref>).
</p>
